CA Stock MarketDetailed Quotes

Bright Minds Biosciences Inc (DRUG)

Watchlist
  • 123.500
  • +4.250+3.56%
15min DelayMarket Closed Apr 17 15:31 ET
1.21BMarket Cap-44.75P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bright Minds Biosciences Inc (DRUG) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2025
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
324.96%6.9M
393.76%13.94M
615.84%5.66M
1,504.23%3.3M
500.66%3.35M
-4.38%1.62M
-61.78%2.82M
-50.10%791.31K
-116.21%-234.74K
-72.83%558.06K
Selling and administrative expenses
101.36%1.09M
77.47%2.57M
115.49%756.41K
84.61%591.94K
85.97%676.16K
34.83%540.93K
-34.29%1.45M
-23.55%351.01K
-15.69%320.64K
-35.38%363.6K
-Selling and marketing expense
26.73%99.1K
932.83%429.66K
2,948.86%152.44K
--112.68K
--86.34K
113.66%78.2K
-65.16%41.6K
-86.34%5K
--0
--0
-General and administrative expense
113.97%990.11K
52.12%2.14M
74.55%603.96K
49.47%479.26K
62.22%589.82K
26.92%462.73K
-32.51%1.4M
-18.12%346.01K
-6.58%320.64K
-34.84%363.6K
Research and development costs
441.50%5.66M
839.36%11.08M
1,049.90%4.78M
574.96%2.69M
2,336.85%2.56M
-14.70%1.05M
-76.40%1.18M
-61.88%416.06K
-153.94%-566.75K
-92.48%105.18K
Other operating expenses
302.07%154.22K
45.88%287.65K
411.21%123.93K
10.18%12.52K
26.38%112.84K
-46.95%38.36K
5.64%197.19K
-31.62%24.24K
-33.88%11.36K
-4.08%89.29K
Operating profit
-324.96%-6.9M
-393.76%-13.94M
-615.84%-5.66M
-1,504.23%-3.3M
-500.66%-3.35M
4.38%-1.62M
61.78%-2.82M
50.10%-791.31K
116.21%234.74K
72.83%-558.06K
Net non-operating interest income (expenses)
18,850.09%818.27K
4,942.54%1.52M
8,715.35%529.54K
3,077.63%476.23K
509.38K
4.32K
30.13K
6.01K
14.99K
0
Non-operating interest income
18,850.09%818.27K
4,942.54%1.52M
8,715.35%529.54K
3,077.63%476.23K
--509.38K
--4.32K
--30.13K
--6.01K
--14.99K
--0
Other net income (expenses)
-188.60%-1.48M
2,127.15%188.77K
8,746.75%1.05M
-12,120.78%-2.42M
-569.72%-107.69K
11,236.25%1.67M
-165.63%-9.31K
-79.52%11.86K
-96.18%-19.83K
-560.06%-16.08K
Gain on sale of security
-188.60%-1.48M
2,127.15%188.77K
10,920.65%1.31M
-13,421.44%-2.68M
-569.72%-107.69K
11,236.25%1.67M
-165.63%-9.31K
-79.52%11.86K
-96.18%-19.83K
-560.06%-16.08K
Special income (charges)
----
----
----
----
----
----
--0
----
----
----
-Less:Impairment of capital assets
----
----
----
----
----
----
--0
----
----
----
Other non-operating income (expenses)
----
----
----
--257.87K
----
----
----
----
----
----
Income before tax
-15,349.58%-7.57M
-336.46%-12.23M
-428.24%-4.09M
-2,380.51%-5.24M
-413.88%-2.95M
102.95%49.61K
61.99%-2.8M
49.38%-773.44K
115.77%229.9K
72.00%-574.14K
Income tax
Earnings from equity interest net of tax
Net income
-15,349.58%-7.57M
-336.46%-12.23M
-428.24%-4.09M
-2,380.51%-5.24M
-413.88%-2.95M
102.95%49.61K
61.99%-2.8M
49.38%-773.44K
115.77%229.9K
72.00%-574.14K
Net income continuous operations
-15,349.58%-7.57M
-336.46%-12.23M
-428.24%-4.09M
-2,380.51%-5.24M
-413.88%-2.95M
102.95%49.61K
61.99%-2.8M
49.38%-773.44K
115.77%229.9K
72.00%-574.14K
Noncontrolling interests
Net income attributable to the company
-15,349.58%-7.57M
-336.46%-12.23M
-428.24%-4.09M
-2,380.51%-5.24M
-413.88%-2.95M
102.95%49.61K
61.99%-2.8M
49.38%-773.44K
115.77%229.9K
72.00%-574.14K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-15,349.58%-7.57M
-336.46%-12.23M
-428.24%-4.09M
-2,380.51%-5.24M
-413.88%-2.95M
102.95%49.61K
61.99%-2.8M
49.38%-773.44K
115.77%229.9K
72.00%-574.14K
Diluted earnings per share
-9,800.00%-0.97
-173.85%-1.78
-241.18%-0.58
-1,580.00%-0.74
-223.08%-0.42
102.27%0.01
67.17%-0.65
57.50%-0.17
112.82%0.05
75.93%-0.13
Basic earnings per share
-9,800.00%-0.97
-173.85%-1.78
-241.18%-0.58
-1,580.00%-0.74
-223.08%-0.42
102.27%0.01
67.17%-0.65
57.50%-0.17
112.82%0.05
75.93%-0.13
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Dec 31, 2025(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 324.96%6.9M393.76%13.94M615.84%5.66M1,504.23%3.3M500.66%3.35M-4.38%1.62M-61.78%2.82M-50.10%791.31K-116.21%-234.74K-72.83%558.06K
Selling and administrative expenses 101.36%1.09M77.47%2.57M115.49%756.41K84.61%591.94K85.97%676.16K34.83%540.93K-34.29%1.45M-23.55%351.01K-15.69%320.64K-35.38%363.6K
-Selling and marketing expense 26.73%99.1K932.83%429.66K2,948.86%152.44K--112.68K--86.34K113.66%78.2K-65.16%41.6K-86.34%5K--0--0
-General and administrative expense 113.97%990.11K52.12%2.14M74.55%603.96K49.47%479.26K62.22%589.82K26.92%462.73K-32.51%1.4M-18.12%346.01K-6.58%320.64K-34.84%363.6K
Research and development costs 441.50%5.66M839.36%11.08M1,049.90%4.78M574.96%2.69M2,336.85%2.56M-14.70%1.05M-76.40%1.18M-61.88%416.06K-153.94%-566.75K-92.48%105.18K
Other operating expenses 302.07%154.22K45.88%287.65K411.21%123.93K10.18%12.52K26.38%112.84K-46.95%38.36K5.64%197.19K-31.62%24.24K-33.88%11.36K-4.08%89.29K
Operating profit -324.96%-6.9M-393.76%-13.94M-615.84%-5.66M-1,504.23%-3.3M-500.66%-3.35M4.38%-1.62M61.78%-2.82M50.10%-791.31K116.21%234.74K72.83%-558.06K
Net non-operating interest income (expenses) 18,850.09%818.27K4,942.54%1.52M8,715.35%529.54K3,077.63%476.23K509.38K4.32K30.13K6.01K14.99K0
Non-operating interest income 18,850.09%818.27K4,942.54%1.52M8,715.35%529.54K3,077.63%476.23K--509.38K--4.32K--30.13K--6.01K--14.99K--0
Other net income (expenses) -188.60%-1.48M2,127.15%188.77K8,746.75%1.05M-12,120.78%-2.42M-569.72%-107.69K11,236.25%1.67M-165.63%-9.31K-79.52%11.86K-96.18%-19.83K-560.06%-16.08K
Gain on sale of security -188.60%-1.48M2,127.15%188.77K10,920.65%1.31M-13,421.44%-2.68M-569.72%-107.69K11,236.25%1.67M-165.63%-9.31K-79.52%11.86K-96.18%-19.83K-560.06%-16.08K
Special income (charges) --------------------------0------------
-Less:Impairment of capital assets --------------------------0------------
Other non-operating income (expenses) --------------257.87K------------------------
Income before tax -15,349.58%-7.57M-336.46%-12.23M-428.24%-4.09M-2,380.51%-5.24M-413.88%-2.95M102.95%49.61K61.99%-2.8M49.38%-773.44K115.77%229.9K72.00%-574.14K
Income tax
Earnings from equity interest net of tax
Net income -15,349.58%-7.57M-336.46%-12.23M-428.24%-4.09M-2,380.51%-5.24M-413.88%-2.95M102.95%49.61K61.99%-2.8M49.38%-773.44K115.77%229.9K72.00%-574.14K
Net income continuous operations -15,349.58%-7.57M-336.46%-12.23M-428.24%-4.09M-2,380.51%-5.24M-413.88%-2.95M102.95%49.61K61.99%-2.8M49.38%-773.44K115.77%229.9K72.00%-574.14K
Noncontrolling interests
Net income attributable to the company -15,349.58%-7.57M-336.46%-12.23M-428.24%-4.09M-2,380.51%-5.24M-413.88%-2.95M102.95%49.61K61.99%-2.8M49.38%-773.44K115.77%229.9K72.00%-574.14K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -15,349.58%-7.57M-336.46%-12.23M-428.24%-4.09M-2,380.51%-5.24M-413.88%-2.95M102.95%49.61K61.99%-2.8M49.38%-773.44K115.77%229.9K72.00%-574.14K
Diluted earnings per share -9,800.00%-0.97-173.85%-1.78-241.18%-0.58-1,580.00%-0.74-223.08%-0.42102.27%0.0167.17%-0.6557.50%-0.17112.82%0.0575.93%-0.13
Basic earnings per share -9,800.00%-0.97-173.85%-1.78-241.18%-0.58-1,580.00%-0.74-223.08%-0.42102.27%0.0167.17%-0.6557.50%-0.17112.82%0.0575.93%-0.13
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +1.04%
Sample Name
Sample Code
 -4.60%
Sample Name
Sample Code
 -6.30%
4
CNOOC
00883
-6.32%
5
YANCHANG PETRO
00346
-8.99%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.87%
Sample Name
Sample Code
 +10.97%
Sample Name
Sample Code
 +6.23%
4
INESA Intelligent Tech Inc.
600602
+6.13%
5
Business-intelligence Of Oriental Nations Corporation
300166
+1.83%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -